These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Identification and purification of factor A-GHRH from hypothalami which releases growth hormone. Currie BL; Johansson KN; Greibrokk T; Folkers K; Bowers CY Biochem Biophys Res Commun; 1974 Sep; 60(2):605-9. PubMed ID: 4609207 [No Abstract] [Full Text] [Related]
25. Diverse effects of glucocorticoids on the hypothalamic pituitary axis in rat growth hormone secretion. Ohyama T; Sato M; Wada Y; Takahara J Endocr J; 1996 Oct; 43 Suppl():S115-7. PubMed ID: 9076357 [No Abstract] [Full Text] [Related]
26. Pituitary growth hormone and hypothalamic somatostatin in young female rats versus old constant estrous female rats. Forman LJ; Sonntag WE; Hylka VW; Meites J Experientia; 1985 May; 41(5):653-4. PubMed ID: 2860005 [TBL] [Abstract][Full Text] [Related]
27. Lack of growth hormone-releasing activity of (pyro)Glu-Ser-Gly-NH2. Schally AV; Redding TW; Takahara J; Coy DH; Arimura A Biochem Biophys Res Commun; 1973 Dec; 55(3):556-62. PubMed ID: 4586612 [No Abstract] [Full Text] [Related]
28. Effect of synthetic growth hormone-releasing inhibiting factor on the secretion of growth hormone and prolactin in rats. Sawano S; Baba Y; Kokubu T; Ishizuka Y Endocrinol Jpn; 1974 Oct; 21(5):399-405. PubMed ID: 4614970 [No Abstract] [Full Text] [Related]
32. [The effect of anesthetics on the basal secretion of immunoreactive growth hormone in rats]. Bluet-Pajot MT; Schaub C C R Acad Hebd Seances Acad Sci D; 1978 Jun; 286(23):1707-10. PubMed ID: 100239 [TBL] [Abstract][Full Text] [Related]
33. [In vivo assay of antisomatotropic activity of somatostatin and two of its analogs]. Franchimont P; Ghys A; Brison J; Haze-Hagelstein MT; Detournay JM; Dremier C; Scarso A; Demoulin A; Dirkx J C R Seances Soc Biol Fil; 1977; 171(3):673-8. PubMed ID: 144010 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of adenosine 3',5'-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone. Borgeat P; Labrie F; Drouin J; Bélanger A; Immer H; Sestanj K; Nelson V; Götz M; Schally AV; Coy DH; Coy EJ Biochem Biophys Res Commun; 1974 Feb; 56(4):1052-9. PubMed ID: 4363638 [No Abstract] [Full Text] [Related]
35. In vitro effects of synthetic somatotropin-release inhibiting factor on cyclic AMP level and GH release in rat anterior pituitary gland. Kaneko T; Oka H; Saito S; Munemura M; Musa K; Oda T Endocrinol Jpn; 1973 Oct; 20(5):535-8. PubMed ID: 4365523 [No Abstract] [Full Text] [Related]
36. Somatostatin inhibition of rat growth hormone release in vitro in the presence of BaCl2 or 3-isobutyl-1-methylxanthine. Schofield JG; Mira-Moser F; Schorderet M; Orci L FEBS Lett; 1974 Sep; 46(1):171-4. PubMed ID: 4371679 [No Abstract] [Full Text] [Related]
37. Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Codd EE; Shu AY; Walker RF Neuropharmacology; 1989 Oct; 28(10):1139-44. PubMed ID: 2812284 [TBL] [Abstract][Full Text] [Related]